Pneumonitis, Interstitial: Clinical Trials

1 trial for Pneumonitis, Interstitial, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Pneumonitis, Interstitial: new trials by email Literature Review of Pneumonitis, Interstitial trials Research Report on Pneumonitis, Interstitial

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rituximab in Interstitial Pneumonitis
Rituximab, Zr-89-rituximab immuno PET/CT - Lung Diseases, Interstitial, Pneumonitis, Interstitial
Phase 2 / Phase 3CompletedHuman Adams202014-09-012018-05-31

Narrower conditions

Lung Diseases, Interstitial (1)

Broader conditions

Lung Diseases (1)  ·  Respiratory Tract Diseases (1)

Interventions

Chromatin Immunoprecipitation Sequencing (1)  ·  Rituximab (1)

Sponsors

Human Adams (1)

Countries

Netherlands (1)

Top investigators

J C Grutters, MD, PhD (1)

Results publications

PMID 36826476